MedPath

Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma

Conditions
Cholesteatoma, Middle Ear
Interventions
Radiation: Multislice computed tomography temporal bone
Registration Number
NCT04551612
Lead Sponsor
Assiut University
Brief Summary

Cholesteatoma is a destructive lesion that progressively expands in the middle ear, mastoid or petrous bone and leads to destruction of the nearby structures. Erosion, which is caused by bone resorption of the ossicular chain and otic capsule, may cause hearing loss, vestibular dysfunction, facial paralysis and intracranial manifestations

Detailed Description

Cholesteatoma has three Classical forms: (1) Congenital, primary or genuine cholesteatoma: occurs behind an intact tympanic membrane. Primary acquired cholesteatoma: looks like a limited diverticulum of the pars flaccida with little or no history of otorrhea. Secondary acquired cholesteatoma: develops with posterosuperior perforations in eardrum and expansion of the disease process into the antrum, mastoid, attic and middle ear. Granulation tissue, polyps and foul- smelling otorrhea are common findings in this type

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • All adults above the age of 18 presented to the Assiut university Clinic with

cholesteatoma will be included in the study.

Exclusion Criteria
  1. Patients with previous mastoid surgery
  2. Patients with Craniofacial anomalies or cleft lip and palate
  3. Pediatric populations ≤ 18 years old
  4. Patients with congenital ear anomalies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with cholesteatomaMultislice computed tomography temporal bonePatients with cholesteatoma in one ear that will compared with the other healthy one.
Primary Outcome Measures
NameTimeMethod
Evaluation of the Level of Middle Cranial Fossa Dura in Patients with Cholesteatoma by multislice computed tomography.One year

determination the level of tegmen in patients with attico-antral diseases by MSCT

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath